Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Autohome
ATHM
$2.67B
| $5.05M | ﹤0.01% |
78,965
-2,055
| -3% | -$169K |
|
2352
ZTO Express
ZTO
$18.3B
| $5.05M | ﹤0.01% |
166,368
-354,240
| -68% | -$10.9M |
|
2353
Kymera Therapeutics
KYMR
$8.51B
| $5.05M | ﹤0.01% |
104,076
+41,628
| +67% | +$1.81M |
|
|
MGI
2354
DELISTED
MoneyGram International, Inc. New
MGI
| $5.04M | ﹤0.01% |
499,538
+76,949
| +18% | +$649K |
|
2355
Outdoor Holding Co
POWW
$249M
| $5.03M | ﹤0.01% |
513,464
+265,040
| +107% | +$1.88M |
|
|
SGFY
2356
DELISTED
Signify Health, Inc.
SGFY
| $5.02M | ﹤0.01% |
164,836
+2,697
| +2% | +$74.1K |
|
2357
ACM Research
ACMR
$5.42B
| $5.01M | ﹤0.01% |
147,162
+5,280
| +4% | +$145K |
|
|
MCFE
2358
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $5M | ﹤0.01% |
178,585
+10,408
| +6% | +$267K |
|
2359
Inseego
INSG
$114M
| $5M | ﹤0.01% |
49,553
+4,155
| +9% | +$380K |
|
2360
OraSure Technologies
OSUR
$279M
| $4.99M | ﹤0.01% |
492,026
+8,841
| +2% | +$86K |
|
2361
JFrog
FROG
$9.66B
| $4.98M | ﹤0.01% |
+109,395
| New | +$4.93M |
|
|
ABTX
2362
DELISTED
Allegiance Bancshares
ABTX
| $4.97M | ﹤0.01% |
129,296
+1,346
| +1% | +$54.3K |
|
|
PAYA
2363
DELISTED
Paya Holdings Inc. Class A Common Stock
PAYA
| $4.93M | ﹤0.01% |
447,663
+204,121
| +84% | +$2.17M |
|
2364
Camden National
CAC
$978M
| $4.92M | ﹤0.01% |
103,085
+2,056
| +2% | +$97.7K |
|
2365
Ouster
OUST
$2.63B
| $4.92M | ﹤0.01% |
+39,357
| New | +$4.2M |
|
2366
HealthStream
HSTM
$819M
| $4.91M | ﹤0.01% |
175,835
+2,324
| +1% | +$58.4K |
|
2367
Arcturus Therapeutics
ARCT
$164M
| $4.89M | ﹤0.01% |
144,621
+6,095
| +4% | +$206K |
|
2368
C3.ai
AI
$1.43B
| $4.88M | ﹤0.01% |
78,062
+1,766
| +2% | +$110K |
|
2369
Rush Street Interactive
RSI
$2.77B
| $4.87M | ﹤0.01% |
396,879
+186,371
| +89% | +$2.5M |
|
2370
Credicorp
BAP
$31.8B
| $4.86M | ﹤0.01% |
40,139
+8,575
| +27% | +$1.12M |
|
|
ATRS
2371
DELISTED
Antares Pharma, Inc.
ATRS
| $4.83M | ﹤0.01% |
1,107,874
+17,435
| +2% | +$71K |
|
2372
Central Garden & Pet Co
CENT
$2.69B
| $4.82M | ﹤0.01% |
113,721
+4,201
| +4% | +$188K |
|
2373
Anterix
ATEX
$1.81B
| $4.82M | ﹤0.01% |
80,256
+2,473
| +3% | +$124K |
|
2374
Horizon Bancorp
HBNC
$1.04B
| $4.8M | ﹤0.01% |
275,411
+4,467
| +2% | +$81.5K |
|
2375
Karyopharm Therapeutics
KPTI
$43.5M
| $4.8M | ﹤0.01% |
31,004
+854
| +3% | +$124K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.